Intelligent Medicine Acquisition (IQMD) Short Interest Ratio & Short Volume

Short interest is the volume of Intelligent Medicine Acquisition shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 1,000 shares of IQMD short. Learn More on Intelligent Medicine Acquisition's current short interest.

Intelligent Medicine Acquisition saw a decline in short interest in October. As of October 31st, there was short interest totaling 1,000 shares, a decline of 33.3% from the previous total of 1,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies compare to Intelligent Medicine Acquisition: Aura FAT Projects Acquisition Corp (0.09%), FutureTech II Acquisition Corp. (0.06%), Newbury Street Acquisition Co. (0.06%), Globalink Investment Inc. (0.00%), Inception Growth Acquisition Limited (0.15%), NorthView Acquisition Co. (0.03%), Blue Ocean Acquisition Corp. (0.04%), Distoken Acquisition Co. (0.00%), Fortune Rise Acquisition Co. (0.01%), Four Leaf Acquisition Co. (0.03%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.81 billion), Charter Communications, Inc. ($3.04 billion), T. Rowe Price Group, Inc. ($1.98 billion), PG&E Co. ($1.92 billion), Lucid Group, Inc. ($1.90 billion), Coinbase Global, Inc. ($1.75 billion), Roblox Co. ($1.58 billion), Rivian Automotive, Inc. ($1.54 billion), Diamondback Energy, Inc. ($1.53 billion), and Old Dominion Freight Line, Inc. ($1.47 billion). View all of the most shorted stocks.

Short selling IQMD is an investing strategy that aims to generate trading profit from Intelligent Medicine Acquisition as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Intelligent Medicine Acquisition occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IQMD, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IQMD, twice per month. The most recent reporting period available is October, 31 2022.